Introduction
11p15 indicating that mutations in two different genes lead to indistinguishable pathologies (8) (9) (10) . Further mapping refinements and molecular cloning lead to the identification of Myotubularin-Related-Protein-2 (MTMR2) and MTMR13/SetBinding-Factor-2 (SBF2) as the disease causing genes of CMT4B1 and CMT4B2 (11) (12) (13) . Mtmr2-deficient mice have been generated and mimic the pathology of CMT4B1 closely (14, 15) .
MTMR2 and MTMR13/SBF2 belong to the family of myotubularin-related proteins (16) . This family consists of fourteen members in human and orthologues have been found throughout the eukaryotic kingdom but not in bacteria. Myotubularin, the founding member of the family, has been originally identified as the diseasecausing gene in X-linked myotubular myopathy (17) . The domain signature of MTMRs is defined by the presence of a phospoinositide (PI)-binding PH-GRAM (pleckstrin homology-glucosyltransferases, Rab-like GTPase activators and myotubularins)-homology domain, a phosphatase domain, and a coiled coil motif.
The phosphatase domain was initially described as a potential protein tyrosine/dual specific phosphatase, but the PIs phosphatidylinositoI (PtdIns)-3-phosphate (P) and PtdIns-3,5-P2 (with myotubularin phosphatase activity specific for the D3 position of the inositol ring) have emerged as the main substrates (16, 18) . The membrane-associated PtdIns-3-P and PtdIns-3,5-P2 regulate trafficking in the endosomal-lysosomal pathway suggesting that the disease mechanisms in MTMR-based diseases are likely to be related to these processes. Interestingly, disturbances of regulatory mechanisms involving PIs seem to become a recurrent theme in CMT since mutations in FIG4, a D5 phosphatase using PtIns-3,5-P2 as substrate, have been recently described to cause CMT4J (19) .
Six members of the myotubularin family, including MTMR13/SBF2, contain inactivating substitutions in the phosphatase domain. Catalytically inactive MTMRs can interact with active MTMRs as modulators of the phosphatase activity, substrate traps, or they influence the subcellular localization. Specifically and in addition to the common motifs, MTMR13/SBF2 contains a classical PtIns-3,4,5-P3-binding PH domain (20) , a DENN (differentially expressed in normal versus neoplastic) domain, and a stretch of 500 amino acids with no homologies to other proteins (Fig. 1A) . MTMR13/SBF2 exists in cells independently as a homodimer, as well as in complex with a homodimer of MTMR2 (20) (21) (22) . The latter association dramatically increases the enzymatic activity of the binding partner MTMR2 (20) .
Here, we have generated Mtmr13/Sbf2-deficient and Mtmr2//Mtmr13/Sbf2 double-deficient mice to dissect the role of this pair of myotubularins in health and disease in vivo.
Results

Gene-trapped disruption of Mtmr13/Sbf2
We have used mouse embryonic stem cells carrying a gene trap insertion in the Mtmr13/Sbf2 locus (XH212; Baygenomics Gene Trap Resource) for the generation of an Mtmr13/Sbf2-deficient mutant mouse line using established procedures (15) . The insertion site of the gene trap cassette was mapped 1267 bp downstream of exon 14 of Mtmr13/Sbf2 (Fig. 1A) . Based on this information, primers I, II and III were designed to discriminate between different alleles and for genotyping (Fig. 1B) . Western blot analysis of sciatic nerve lysates of Mtmr13/Sbf2-deficient and wt littermates revealed that the Mtmr13/Sbf2 protein was absent (Fig. 1C) In a first step, we analyzed whether alterations in Mtmr2 or Mtmr13/Sbf2 expression alter the protein levels of its respective binding partner in the sciatic nerve of mutant animals. Western blot analysis of sciatic nerve lysates from twelve months-old animals revealed that Mtmr2 levels were unchanged in Mtmr13/Sbf2-deficient mice ( Fig. 2A) . Vice versa, Mtmr13/Sbf2 levels remained unaltered in Mtmr2-deficient mice (Fig. 2B) . Bolino et al. (14) and Bolis et al. (23) have reported an interaction of Mtmr2 with Sap97. They detected also reduced expression of Sap97 in the sciatic nerves of their strain of Mtmr2-deficient mice.
Here, we confirmed these findings in our strain of Mtmr2-mutant mice (15) . We continued to test whether loss of Mtmr13/Sbf2 would also reduce the levels of Sap97 by reasoning that loss of the Mtmr2 interaction partner Mtmr13/Sbf2 might affect indirectly the interaction between Mtmr2 and Sap97 within a putative larger complex. However, the levels of Sap97 were not significantly different to wt in Mtmr13/Sbf2-deficient mice (Fig. 2C) . Consistent with these findings, we found a comparable reduction of Sap97 in Mtmr2//Mtmr13/Sbf2-double deficient mice as in Mtmr2-single mutants (Fig. 2D) . We conclude that the interaction of Mtmr13/Sbf2 with Mtmr2 and the interaction between Mtmr2 and Sap97 are unlikely to be intimately connected. This conclusion was also supported by coimmunoprecipitation experiments revealing no apparent differences in the interaction of Mtmr2 with Sap97 between wt and Mtmr13/Sbf2-deficient sciatic nerves (data not shown).
Behavioral analysis
Visual examination of both Mtmr13/Sbf2-deficient and Mtmr2//Mtmr13/Sbf2-double deficient mice revealed no obvious signs of tremor or major functional disability, similar to what we had observed in the Mtmr2-deficient model of CMT4B1 (15) . Therefore, we performed a Rotarod test to assess whether a behavioral difference related to motor function was detectable using this assay.
At the age of four months, Mtmr13/Sbf2-deficient mice were not distinguishable from wt mice (Fig. 3A) . At twelve months of age, however, Mtmr13/Sbf2 mutant animals showed a significantly reduced performance compared to their wt control littermates ( Fig. 3B) and similar results were obtained with Mtmr2//Mtmr13/Sbf2-double deficient mice (Fig. 3C ). No significant difference between the two mutant strains was observed. Based on the results at this point, we decided not to perform further detailed studies on Mtmr2//Mtmr13/Sbf2-double deficient mice.
Qualitatively, we did not observe major pathology differences compared to the single Mtmr13/Sbf2 mutants (data not shown).
Electrophysiology of peripheral nerves of Mtmr13/Sbf2-deficient mice Motor nerve conduction of sciatic nerves was studied in Mtmr13/Sbf2-deficient mice at the age of four and twelve months (Fig. 4) . In four months-old animals, the CMAP amplitude was not significantly different in Mtmr13/Sbf2-deficient mice compared to wt (18.0 ± 3.7 mV vs. 14.0 ± 3.6 mV). At twelve months of age, however, Mtmr13/Sbf2-deficient mice showed a significant reduction of the CMAP (7.3 ± 1.1 mV vs. 16.3± 2.2 mV in wt mice) and a slightly prolonged Fwave latency of 5.1 ± 0.2 ms (4.4 ± 0.1 ms in wt). Such a very mildly prolonged F-wave latency was already present in four months-old Mtmr13/Sbf2-deficient animals (4.7 ± 0.2 ms vs. 4.2 ± 0.2 ms in wt). A tendency towards NCV slowing was not significant at both ages examined.
Progressive myelin abnormalities in peripheral nerves of Mtmr13/Sbf2-deficient mice Focally folded myelin is the histological hallmark of both CMT4B1 and CMT4B2.
Thus, we focused our analysis on the presence, time course, and distribution of focal dysmyelination. At four months of age, Mtmr13/Sbf2-deficient mice showed numerous sciatic nerve fibres with focally folded myelin (Fig. 5) . Abnormalities included both infoldings and outfoldings of the entire myelin sheath which particularly affected large caliber fibres but also smaller, thinly myelinated fibres.
Non-myelinated fibres appeared normal. At higher magnification, sciatic nerve cross sections of mutant mice were littered with various degrees of dysmyelination ranging from focal budding of the myelin sheath to multiple or combined infoldings and outfoldings.
Abnormal myelin structures were first but rather sporadically observed in the sciatic nerves of Mtmr13/Sbf2-deficient mice already at the age of three weeks (Fig. 6 A,B) . Irregular myelin folds were easily detectable although of low complexity. Quantitative analysis of these pathological structures revealed a significant increase in numbers compared to wt animals ( Fig. 7A) . Next, since CMT is usually associated with a clinically progressive time course, we followed the qualitative and quantitative progression of the pathology over time. Thus, we examined sciatic nerves at the age of four months and fifteen months ( (24) . However, using computer-aided morphometry, we did not detect significant alterations in myelin thickness and axon diameter in Mtmr13/Sbf2-deficient sciatic nerves ( Fig. 7 B,C), consistent with our identical previous findings in Mtrm2-deficient mice (15) . In agreement with these data, we did not observe Schwann cell onion bulb formation as the classical indicators of demyelination and remyelination.
Motor and sensory nerves are affected in Mtmr13/Sbf2-deficient mice CMT4B2 is classified as a motor and sensory neuropathy. Thus, we analyzed whether these mixed symptoms were reflected in pathological aberrations in both motor and sensory nerves. We chose to examine the ventral roots containing exclusively axons derived from motor neurons and dorsal roots for sensory axons. In both locations, the pathological hallmarks of myelin misfoldings were barely detectable at the age of four months ( Fig. 8 A, B) , in contrast to the more distally (with respect to the neuronal cell bodies) located sciatic nerve (Fig. 6 D) which contains both motor and sensory axons. These findings indicate that the pathology is more severe in distal compared to proximal parts of PNS nerves. At the age of fifteen months, myelin misfoldings were prominently visible in ventral and dorsal roots suggesting that both motor and sensory nerves become affected in a progressive manner over time ( Fig. 8 C, D) .
Complex structures of misfolded myelin in Mtmr13/Sbf2-deficient mice In order to get some detailed insights into the fine structure of aberrant Schwann cell-axon units in our mutant mice, we performed ultrastructural analysis using electron microscopy. Figure 9 shows a collection of pictures to provide a sampling overview of the different aberrant structures that we have observed.
The myelin misfoldings invariably originated from compacted myelin and showed an identical number of myelin lamellae in both myelin misfoldings and the myelin sheath they originated from (Fig. 9D , quantitative data not shown). Within myelin misfoldings, we observed normal compaction and periodicity of the myelin sheath. In general, the impression of pathological alterations was dominated by myelin outfoldings with strongly variable complexity ( Fig. 9 A-D) . The most common formation consisted of one or multiple outfoldings of different size adjacent to a myelinated large caliber axon, and multiple outfoldings showed a tendency to form groups (Fig. 9 C) . Aberrant myelin loops were always ensheathed by the plasma membrane of the related Schwann cell (Fig. 9 A) .
Myelin infoldings were also prominent. They usually presented as finger-like inversions of the myelin sheath (Fig. 9 E) or circular inclusions within the myelinated nerve fiber (Fig. 9 F) . Entraining Schwann cell cytoplasm on their outer surface, they protrude far into the axon and displace the axoplasm (Fig.   9E ). The formation of double circles (Fig. 9 F,G) is most likely due to the retrograde inversion of a single infolding since, at higher magnifications, we observed axonal material in the gap between the inner and outer infolding.
Alternatively, the nesting of two distinct infoldings may have led to the doublecircle appearance.
On electrophysiological examination, older Mtmr13/Sbf2-deficient mice showed a reduction of the CMAP indicating axonal loss or damage. Thus, we also carefully looked for axonal pathology. Degeneration of whole Schwann cell-axon units ( Fig. 9 K,L) was not observed in young mutants, but was sporadically present at four months and rather frequent at fifteenth months. Lateral dislocation of the axon by myelin infoldings and vacuolar alteration of the axoplasm (Fig. 9 I,J) was often observed. We occasionally found also myelinated nerve fibers not affected by myelin misfoldings but with a conspicuous widening of the periaxonal space (Fig. 9 H) .
The amazing complexity of myelin misfoldings and the consequences for the affected Schwann cell-axon units, however, can be best appreciated on longitudinal sections ( (Fig. 9 M, P) . Occasionally, misfoldings of the myelin sheath had a larger diameter than the original nerve fibre, or lead to spatial disarrangement of the normal fibre anatomy like affecting the node of Ranvier (Fig. 9 N) . Relating these structural changes back to the molecular and cellular functions (and misfunctions in disease) of MTMR13/SBF2 will be a major challenge for the future. On a pure morphological level, the pathological observations in Mtmr13/Sbf2-deficient mice are very reminiscent of our observations in Mtmr2-deficient animals consistent with the biochemical finding suggesting a crucial role for a high-molecular complex containing both MTMR13/SBF2 and MTMR2 in the biology of myelinated peripheral nerves, possibly in the regulation of membrane trafficking.
Discussion
We report the generation and analysis of the first animal model for the human neuropathy CMT4B2 by disruption of Mtmr13/Sbf2 in mice. To our knowledge, this is also the first animal model for a genetically inherited human disease caused by mutations affecting an inactive member of the myotubularin phosphatase family. The aim of this study was three-fold. First, we wanted to provide the formal proof that mutations in Mtmr13/Sbf2 are indeed causative for CMT4B2. Second, we anticipated that the generation of an animal model for this particular form of CMT will contribute critically to the dissection of the underlying disease mechanisms, especially with regard to the development and the progression of the disorder but also by providing appropriate means for further cell biological and biochemical analysis. Finally, recent reports relying on the analysis of appropriate CMT animal models have provided hopeful projections for treatment strategies encouraging the development of further refined animal models (25) (26) (27) (28) .
Initial analysis of Mtmr13/Sbf2-deficient mice as animal models for CMT4B2 revealed behavioral deficits in the rotarod assay not in four months but in twelve months-old mice indicating significant motor impairments. This finding is consistent with the general clinical features of CMT4B2 patients that involve motor and sensory disturbances (11, 12) . Further analysis by light microscopy and ultrastructural analysis of peripheral nerves by electron microscopy showed prominent and complex myelin infoldings and outfoldings reminiscent of CMT4B2 (9) . Our mouse model allowed us to follow the development of these pathological features in a temporal fashion by analyzing peripheral nerves at different time points. Both the number and complexity of the unusual myelin figures increased gradually over time in a continuous fashion with little inter-animal variability.
Some signs of axonal damage were also observed, in particular in older animals.
Nevertheless, we did not find obvious evidence for primary demyelination and remyelination as judged from the lack of major Schwann cell onion bulb formations in the mouse mutant nerves up to the age of fifteen months (last time point examined) and no decrease in myelin thickness. Consistent with these findings, we observed only minor signs of reduced NCV (prolonged F-wave latency). This appears to be in contrast to the strongly reduced NCV in CMT4B2 patients (9, 12) . Although the reason for this discrepancy is not yet clear, it should be noted that animal models for the related condition CMT4B1, associated with Mtmr2 deficiency, showed also much milder electrophysiological abnormalities compared to the corresponding human patients (14, 15) . It remains to be determined whether this feature is due to some specific mechanistic aspects of CMT4B-type neuropathies. Similarly, we did not observe a striking loss of myelinated large caliber axons in Mtmr13/Sbf2-deficient mice as has been reported based on qualitative assessments of sural nerve biopsies of CMT4B2 patients (9, 12) . Demyelination and in particular secondary axonal loss might be more pronounced in humans in these distally accentuated neuropathies due to basic physiological species differences that include much longer nerves and the longer life span of humans compared to mice (5). We found, however, a correlation between the rather poor performance of the mutants in the functional testing on the rotarod and the reduction of the CMAP amplitude. Since we did not observe major axonal loss, we favour the hypothesis that distal conduction block occurs in a significant proportion of fibres, possibly due to axonal constrictions by major myelin infoldings. Perinodal abnormalities may also lead to conduction block in the affected fibres resulting in reduced CMAP amplitudes. have elegantly shown that loss of MTMR2 is sufficient to cause the typical myelin abnormalities in a Schwann cell-autonomous manner (23) . Complementary experiments will be necessary to answer this question also for MTMR13/SBF2.
Although its not known in detail which signaling cascades are involved in the molecular pathogenesis of CMT4B1 and CMT4B2, the related processes involve regulation at various levels (20, 22, 29) . MTMR13/SBF2 appears to act at least 1) as a regulator of the MTMR2 phosphatase activity, 2) as a protector of the PI substrates, and 3) as an adaptor regulating the localization of active MTMR2.
Membrane PI-binding GRAM-PH and PH domains in MTMR2 as well as MTMR13/SBF2 play a major role in at least some of these processes, possibly by regulating vesicular and membrane trafficking in Schwann cells since loss of these proteins is associated with uncontrolled folding of myelin and CMT4B.
Recently, mutations in the Rho-type GTPase Guanine Nucleotide Exchange Factor (GEF) Frabin/FGD4 have been shown to be associated with CMT4H characterized by abundant myelin outfoldings (30, 31) . In addition to a RhoGEF (DH) domain, Frabin contains two PH domains and a presumably PI-binding FYVE domain. It is tantalizing to speculate that the presence of PI-binding domains in the disease-causing MTMR2, MTMR13/SBF2 and Frabin/FGD4 genes and the striking correlation with myelin outfoldings might be related to overlapping disease mechanisms. Further, how Dlg1/Sap97 and neurofilament light chain protein as described interaction partners of MTMR2 are involved in the disease process causing CMT4B remains to be determined (14, 32) .
In conclusion, we have generated an animal model for CMT4B2. In combination with the available Mtmr2-mutant mice, the Mtmr13/Sbf2-deficient animals provide valuable tools for future mechanistic studies in hereditary neuropathies characterized by myelin outfoldings and infoldings. 
Materials and Methods
Generation of
Rotarod test
Mice were placed on a rotarod apparatus (TSE Systems, Germany) and the time spent on the rotating rod, rotating from 4 to 40 rpm, was measured. Four trials per day, every two hours, on four consecutive days were performed with a maximal trial length of 10 min.
Neurophysiology
Motor nerve conduction of sciatic nerves was investigated in anesthesized animals as described previously (35) . CMAP and F-wave were recorded with needle electrodes in the foot muscles after supramaximal stimulation of the tibial nerve at the ankle and stimulation of the sciatic nerve at the sciatic notch.
Statistical analysis was performed using Student's t-test.
Electron microscopy
Animals were anesthesized and sequentially perfused with 0.25 mg/ml heparin in 0.1 M PBS and a fixative solution containing 4% PFA and 2% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4). Sciatic nerves were dissected, postfixed for 24 h at 4°C, osmicated for 2 h in 2% osmium tetroxide, washed in distilled water several times, dehydrated in ascending acetone, and embedded in Spurr's medium (36) . Ninety nanometer ultrathin sections cut on an Ultracut E microtome (Reichert-Jung, Heidelberg, Germany) were mounted on copper grids and contrasted with uranyl acetate and lead citrate. Digital photographs were taken on a Philips EM 208 S transmission electron microscope using the iTEM® software (Olympus Soft Imaging Solutions, Muenster, Germany).
Morphometric analysis and quantification of focally folded myelin
Sciatic nerves from intracardially perfused animals were osmicated and embedded in Spurr's medium as described above. 0.5 um semithin sections were stained with alkaline toluidine blue under standardized conditions to obtain identical results with regard to contrast and color intensity. Semithin sections were visualized in a Leica DMRX microscope at 400-fold magnification, and a series of partially overlapping images covering the cross-sectional area was captured with a SPOT digital camera (Diagnostic Instruments, Sterling Heights, MI). In order to obtain a composite image of the entire cross section, single images were pasted together using a Gaussian filter. Image processing and morphometric data collection was performed using the analySIS® software (Olympus Soft Imaging Solutions, Muenster, Germany). A macro was designed to meet the specific requirements of morphometric analysis. To discriminate axons and myelin sheaths, we defined a grey-scale threshold level for axon and myelin profiles. For each nerve fiber, both axon and myelin area was measured, and the diameter of axons and myelinated fibers was mathematically deduced from a circle of an equivalent area. Paranodes, Schwann cell nuclei, nerve fibers with focally folded myelin, and unmyelinated fibers were manually excluded from morphometry. We analyzed two sciatic cross sections per animal (mutant and wt), and sections were taken from different levels 1.5 mm apart. For quantification of dysmyelinated nerve fibers, we determined the total number of fibers on each cross section, and the proportion of myelinated fibers showing focally folded myelin was calculated. 
